市場調查報告書
商品編碼
1134166

全球心血管應用市場 – 預測到 2027 年

Global Cardiovascular Application Market - Forecast till 2027

出版日期: | 出版商: Market Research Future | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

人們越來越意識到威脅生命的心臟疾病對人類健康的影響、微創治療的進步、對影像引導的需求不斷增長、藥物使用的增加以及健康意識的提高正在推動心血管應用市場的增長。

本報告研究和分析全球心血管應用市場,提供包括市場動態、市場分析、競爭格局和公司概況在內的系統信息。

內容

報告章節序言

第二章市場介紹

  • 定義
  • 調查範圍
  • 調查目的
  • 假設和限制
    • 假設
    • 限制
  • 市場結構

第三章研究方法

  • 初步調查調查方法
  • 二次調查調查方法
  • 市場份額分析
  • 市場價格法

第四章市場因素分析

  • 價值鏈分析
    • 研發與設計
    • 製造
    • 分銷和銷售
    • 售後監控
  • 波特五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭強度
  • 供需:差距分析
  • 價格分析

第五章市場動態

  • 簡介
  • 驅動程序
    • 心血管疾病患病率不斷上升
    • 優惠的退款政策
    • 不斷增長的老年人口
  • 限制因素
    • 嚴格的監管準則
  • 大趨勢
  • 宏觀經濟指標

第 6 章全球心血管應用市場:設備

第 7 章全球心血管應用市場:按最終用戶分類

  • 簡介
  • 醫院
  • 心臟中心
  • 門診中心和家庭護理
  • 學術機構

第 8 章全球心血管應用市場:按地區劃分

  • 簡介
  • 美洲
    • 北美
    • 南美洲
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 大韓民國
    • 亞太地區其他地區
  • 中東和非洲
    • 阿拉伯聯合酋長國
    • 沙特阿拉伯
    • 阿曼
    • 科威特
    • 卡塔爾
    • 其他中東和非洲

第九章公司情況

  • 簡介
  • 公司份額分析
  • 主要發展

第 10 章公司簡介

  • ABBOTT
  • GENERAL ELECTRIC COMPANY
  • MEDTRONIC
  • BOSTON SCIENTIFIC CORPORATION
  • KONINKLIJKE PHILIPS N.V
  • TERUMO
  • STRYKER CORPORATION

第十一章結論

  • 主要發現
    • CEO 的觀點
    • 未滿足的需求
    • 值得關注的重點公司

第十二章附錄

  • 討論見解
  • 參考資料
目錄
Product Code: MRFR/MED/3817-CR

Market Overview

Cardiovascular disease is now a serious, life-threatening condition that is becoming more common all over the world. The cardiovascular disease covers illnesses like hypertension and hyperlipidemia as well as disorders of the heart or blood arteries. The cardiovascular application market size is significantly influenced by several factors and trends in the current cardiovascular application market 2021. The devastating effects of life-threatening heart disorders on human health are becoming more widely recognized. The advancement of minimally invasive therapeutic structures has promoted the use of high-quality tools. The demand for image guidance has grown, which has fueled its expansion. Cardiovascular problems may affect a sizable section of the world's population due to the trend in today's lifestyle. Increased medicine use is mostly a result of increased research and novel therapies in this area.

The expansion of the global market is linked to rising health awareness and a corresponding rise in product launches. A comprehensive strategy is comparable to the need for potent treatments. The competition in the market for cardiovascular applications has grown as a result of the competitors' discovery of various cutting-edge medications. The market for cardiovascular applications is primarily driven by an increase in the efficacy of less expensive generics. A medication like Eliquis is a risk-reducer.

REGIONAL ANALYSIS

An income of USD 21.89 billion was created by North America and involved a prevailing locale in the general market. The predominance of hazardous cardiovascular illness alongside the new item was sent off in the locale which drove the cardiovascular application market development. Because of the development of vital pay across the Asia Pacific district. The predominance of this illness inq key nations and the rising status of cardiovascular infection is the main source and is likewise expected to drive the cardiovascular application market.

Europe shows huge development since this infection causes critical passing across the region.

SEGMENT OVERVIEW

The type of segment is formed of hypertensive, antihyperlipidemic, anticoagulants, antiplatelet drugs, and many others.

The area of cardiovascular medicine benefited from the use of technology as it advanced. Smart device notifications are sent to patients when arrhythmias are detected using AI algorithms. Use a TAVR to replace your valves. Consumers and healthcare professionals can now better monitor a patient's health thanks to wearable technology. Physicians may now access technology and learn new skills more quickly because to the new EP technologies. The market has continued to grow thanks to technological advancements.

Some hospitals have embraced digital technologies that help doctors diagnose patients more accurately, treat patients remotely, remind them to take their medications, and manage high-risk care.

Major Players

The key competitors of the global cardiovascular application market include Pfizer Inc, Bayer AG, Sanofi, Novartis AG, Merck and Co Inc, Janssen Pharmaceuticals Inc, Gilead Sciences Inc, etc.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 REPORT PROLOGUE

2 MARKET INTRODUCTION

  • 2.1 DEFINITION 17
  • 2.2 SCOPE OF STUDY 17
  • 2.3 RESEARCH OBJECTIVE 17
  • 2.4 ASSUMPTIONS & LIMITATIONS 18
    • 2.4.1 ASSUMPTIONS 18
    • 2.4.2 LIMITATIONS 18
  • 2.5 MARKET STRUCTURE 18

3 RESEARCH METHODOLOGY

  • 3.1 PRIMARY RESEARCH METHODOLOGY 20
  • 3.2 SECONDARY RESEARCH METHODOLOGY 21
  • 3.3 MARKET SHARE ANALYSIS 21
  • 3.4 MARKET PRICING APPROACH

4 MARKET FACTOR ANALYSIS

  • 4.1 VALUE CHAIN ANALYSIS 23
    • 4.1.1 R&D AND DESIGNING 23
    • 4.1.2 MANUFACTURING 24
    • 4.1.3 DISTRIBUTION & SALES 24
    • 4.1.4 POST-SALES MONITORING 24
  • 4.2 PORTER'S FIVE FORCES MODEL 25
    • 4.2.1 BARGAINING POWER OF SUPPLIERS 25
    • 4.2.2 BARGAINING POWER OF BUYERS 26
    • 4.2.3 THREAT OF NEW ENTRANTS 26
    • 4.2.4 THREAT OF SUBSTITUTES 26
    • 4.2.5 INTENSITY OF RIVALRY 26
  • 4.3 DEMAND & SUPPLY: GAP ANALYSIS 27
  • 4.4 PRICING ANALYSIS 27

5 MARKET DYNAMICS

  • 5.1 INTRODUCTION 28
  • 5.2 DRIVERS 29
    • 5.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES 29
    • 5.2.2 FAVOURABLE REIMBURSEMENT POLICIES 30
    • 5.2.3 INCREASING GERIATRIC POPULATION 31
  • 5.3 RESTRAINTS 32
    • 5.3.1 STRICT REGULATORY GUIDELINES 32
  • 5.4 MEGA TRENDS 33
  • 5.5 MACROECONOMIC INDICATORS 33

6 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY DEVICE

  • 6.1 INTRODUCTION 35
  • 6.2 CARDIAC MONITORS 36
  • 6.3 CARDIAC PACEMAKERS 37
  • 6.4 CARDIAC DEFIBRILLATORS

7 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY END USER

  • 7.1 INTRODUCTION 40
  • 7.2 HOSPITALS 41
  • 7.3 CARDIAC CARE CENTERS 42
  • 7.4 AMBULATORY CENTERS & HOME CARE 43
  • 7.5 ACADEMIC CENTERS

8 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY REGION

  • 8.1 INTRODUCTION 45
  • 8.2 AMERICAS 47
    • 8.2.1 NORTH AMERICA 50
      • 8.2.1.1 U.S. 53
      • 8.2.1.2 CANADA 56
    • 8.2.2 SOUTH AMERICA 58
  • 8.3 EUROPE 61
    • 8.3.1 WESTERN EUROPE 64
      • 8.3.1.1 GERMANY 68
      • 8.3.1.2 FRANCE 70
      • 8.3.1.3 U.K. 73
      • 8.3.1.4 ITALY 75
      • 8.3.1.5 SPAIN 78
      • 8.3.1.6 REST OF WESTERN EUROPE 80
    • 8.3.2 EASTERN EUROPE 83
  • 8.4 ASIA PACIFIC 86
    • 8.4.1 JAPAN 90
    • 8.4.2 CHINA 92
    • 8.4.3 INDIA 95
    • 8.4.4 AUSTRALIA 97
    • 8.4.5 REPUBLIC OF KOREA 100
    • 8.4.6 REST OF ASIA PACIFIC 102

  • 8.5 MIDDLE EAST & AFRICA 105
    • 8.5.1 UNITED ARAB EMIRATES 109
    • 8.5.2 SAUDI ARABIA 111
    • 8.5.3 OMAN 114
    • 8.5.4 KUWAIT 116
    • 8.5.5 QATAR 119
    • 8.5.6 REST OF MIDDLE EAST & AFRICA 121

9 COMPANY LANDSCAPE

  • 9.1 INTRODUCTION 125
  • 9.2 COMPANY SHARE ANALYSIS 125
  • 9.3 KEY DEVELOPMENTS 126

10 COMPANY PROFILES

  • 10.1 ABBOTT 128
    • 10.1.1 COMPANY OVERVIEW 128
    • 10.1.2 FINANCIALS 128
    • 10.1.3 PRODUCTS 128
    • 10.1.4 STRATEGY 128
    • 10.1.5 KEY DEVELOPMENTS 128
  • 10.2 GENERAL ELECTRIC COMPANY 129
    • 10.2.1 COMPANY OVERVIEW 129
    • 10.2.2 FINANCIALS 129
    • 10.2.3 PRODUCTS 129
    • 10.2.4 STRATEGY 129
    • 10.2.5 KEY DEVELOPMENTS 129
  • 10.3 MEDTRONIC 130
    • 10.3.1 COMPANY OVERVIEW 130
    • 10.3.2 FINANCIALS 130
    • 10.3.3 PRODUCTS 130
    • 10.3.4 STRATEGY 130
    • 10.3.5 KEY DEVELOPMENTS 130
  • 10.4 BOSTON SCIENTIFIC CORPORATION 131
    • 10.4.1 COMPANY OVERVIEW 131
    • 10.4.2 FINANCIALS 131
    • 10.4.3 PRODUCTS 131
    • 10.4.4 STRATEGY 131
    • 10.4.5 KEY DEVELOPMENTS 131
  • 10.5 KONINKLIJKE PHILIPS N.V 132
    • 10.5.1 COMPANY OVERVIEW 132
    • 10.5.2 FINANCIALS 132
    • 10.5.3 PRODUCTS 132
    • 10.5.4 STRATEGY 132
    • 10.5.5 KEY DEVELOPMENTS 132
  • 10.6 TERUMO 133
    • 10.6.1 COMPANY OVERVIEW 133
    • 10.6.2 FINANCIALS 133
    • 10.6.3 PRODUCTS 133
    • 10.6.4 STRATEGY 133
    • 10.6.5 KEY DEVELOPMENTS 133
  • 10.7 STRYKER CORPORATION 134
    • 10.7.1 COMPANY OVERVIEW 134
    • 10.7.2 FINANCIALS 134
    • 10.7.3 PRODUCTS 134
    • 10.7.4 STRATEGY 134
    • 10.7.5 KEY DEVELOPMENTS 134

11 CONCLUSION

  • 11.1 KEY FINDINGS 135
    • 11.1.1 CEO'S VIEWPOINT 135
    • 11.1.2 UNMET NEEDS 135
    • 11.1.3 KEY COMPANIES TO WATCH

12 APPENDIX

  • 12.1 DISCUSSION BLUE PRINT 136
  • 12.2 REFERENCES

LIST OF TABLES

  • TABLE 1 PRIMARY INTERVIEWS 20
  • TABLE 2 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 35
  • TABLE 3 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR CARDIAC MONITORS BY REGION, 2020 TO 2027 (USD MILLION) 36
  • TABLE 4 GLOBAL CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 36
  • TABLE 5 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR CARDIAC MONITORS BY REGION, 2020 TO 2027 (USD MILLION) 37
  • TABLE 6 GLOBAL CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 37
  • TABLE 7 GLOBAL IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 38
  • TABLE 8 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR CARDIAC DEFIBRILLATORS BY REGION, 2020 TO 2027 (USD MILLION) 38
  • TABLE 9 GLOBAL CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 39
  • TABLE 10 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 41
  • TABLE 11 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR HOSPITALS BY REGION, 2020 TO 2027 (USD MILLION) 41
  • TABLE 12 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR CARDIAC CARE CENTERS BY REGION, 2020 TO 2027 (USD MILLION) 42
  • TABLE 13 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR AMBULATORY CENTER & HOME CARE BY REGION, 2020 TO 2027 (USD MILLION) 43
  • TABLE 14 GLOBAL CARDIOVASCULAR APPLICATION MARKET FOR ACADEMIC CENTERS BY REGION, 2020 TO 2027 (USD MILLION) 44
  • TABLE 15 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 46
  • TABLE 16 AMERICAS CARDIOVASCULAR APPLICATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 48
  • TABLE 17 AMERICAS CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 48
  • TABLE 18 AMERICAS CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 48
  • TABLE 19 AMERICAS CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 49
  • TABLE 20 AMERICAS IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 49
  • TABLE 21 AMERICAS CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 49
  • TABLE 22 AMERICAS CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 50
  • TABLE 23 NORTH AMERICA CARDIOVASCULAR APPLICATION MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 51
  • TABLE 24 NORTH AMERICA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 51
  • TABLE 25 NORTH AMERICA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 51
  • TABLE 26 NORTH AMERICA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 52
  • TABLE 27 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 52
  • TABLE 28 NORTH AMERICA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 52
  • TABLE 29 NORTH AMERICA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 53
  • TABLE 30 U.S. CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 53
  • TABLE 31 U.S. CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 54
  • TABLE 32 U.S. CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 54
  • TABLE 33 U.S. IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 54
  • TABLE 34 U.S. CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 55
  • TABLE 35 U.S. CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 55
  • TABLE 36 CANADA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 56
  • TABLE 37 CANADA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 56
  • TABLE 38 CANADA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 56
  • TABLE 39 CANADA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 57
  • TABLE 40 CANADA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 57
  • TABLE 41 CANADA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 58
  • TABLE 42 SOUTH AMERICA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 58
  • TABLE 43 SOUTH AMERICA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 59
  • TABLE 44 SOUTH AMERICA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 59
  • TABLE 45 SOUTH AMERICA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 59
  • TABLE 46 SOUTH AMERICA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 60
  • TABLE 47 SOUTH AMERICA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 60
  • TABLE 48 EUROPE CARDIOVASCULAR APPLICATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 61
  • TABLE 49 EUROPE CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 62
  • TABLE 50 EUROPE CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 62
  • TABLE 51 EUROPE CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 62
  • TABLE 52 EUROPE IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 63
  • TABLE 53 EUROPE CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 63
  • TABLE 54 EUROPE CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 64
  • TABLE 55 WESTERN EUROPE CARDIOVASCULAR APPLICATION MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 65
  • TABLE 56 WESTERN EUROPE CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 65
  • TABLE 57 WESTERN EUROPE CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 66
  • TABLE 58 WESTERN EUROPE CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 66
  • TABLE 59 WESTERN EUROPE IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 66
  • TABLE 60 WESTERN EUROPE CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 67
  • TABLE 61 WESTERN EUROPE CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 67
  • TABLE 62 GERMANY CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 68
  • TABLE 63 GERMANY CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 68
  • TABLE 64 GERMANY CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 68
  • TABLE 65 GERMANY IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 69
  • TABLE 66 GERMANY CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 69
  • TABLE 67 GERMANY CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 70
  • TABLE 68 FRANCE CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 70
  • TABLE 69 FRANCE CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 71
  • TABLE 70 FRANCE CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 71
  • TABLE 71 FRANCE IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 71
  • TABLE 72 FRANCE CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 72
  • TABLE 73 FRANCE CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 72
  • TABLE 74 U.K. CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 73
  • TABLE 75 U.K. CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 73
  • TABLE 76 U.K. CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 73
  • TABLE 77 U.K. IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 74
  • TABLE 78 U.K. CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 74
  • TABLE 79 U.K. CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 75
  • TABLE 80 ITALY CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 75
  • TABLE 81 ITALY CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 76
  • TABLE 82 ITALY CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 76
  • TABLE 83 ITALY IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 76
  • TABLE 84 ITALY CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 77
  • TABLE 85 ITALY CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 77
  • TABLE 86 SPAIN CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 78
  • TABLE 87 SPAIN CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 78
  • TABLE 88 SPAIN CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 78
  • TABLE 89 SPAIN IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 79
  • TABLE 90 SPAIN CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 79
  • TABLE 91 SPAIN CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 80
  • TABLE 92 REST OF WESTERN EUROPE CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 80
  • TABLE 93 REST OF WESTERN EUROPE CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 81
  • TABLE 94 REST OF WESTERN EUROPE CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 81
  • TABLE 95 REST OF WESTERN EUROPE IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 82
  • TABLE 96 REST OF WESTERN EUROPE CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 82
  • TABLE 97 REST OF WESTERN EUROPE CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 83
  • TABLE 98 EASTERN EUROPE CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 83
  • TABLE 99 EASTERN EUROPE CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 84
  • TABLE 100 EASTERN EUROPE CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 84
  • TABLE 101 EASTERN EUROPE IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 84
  • TABLE 102 EASTERN EUROPE CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 85
  • TABLE 103 EASTERN EUROPE CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 85
  • TABLE 104 ASIA PACIFIC CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 87
  • TABLE 105 ASIA PACIFIC CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 88
  • TABLE 106 ASIA PACIFIC CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 88
  • TABLE 107 ASIA PACIFIC IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 88
  • TABLE 108 ASIA PACIFIC CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 89
  • TABLE 109 ASIA PACIFIC CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 89
  • TABLE 110 JAPAN CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 90
  • TABLE 111 JAPAN CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 90
  • TABLE 112 JAPAN CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 90
  • TABLE 113 JAPAN IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 91
  • TABLE 114 JAPAN CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 91
  • TABLE 115 JAPAN CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 92
  • TABLE 116 CHINA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 92
  • TABLE 117 CHINA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 93
  • TABLE 118 CHINA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 93
  • TABLE 119 CHINA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 93
  • TABLE 120 CHINA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 94
  • TABLE 121 CHINA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 94
  • TABLE 122 INDIA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 95
  • TABLE 123 INDIA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 95
  • TABLE 124 INDIA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 95
  • TABLE 125 INDIA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 96
  • TABLE 126 INDIA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 96
  • TABLE 127 INDIA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 97
  • TABLE 128 AUSTRALIA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 97
  • TABLE 129 AUSTRALIA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 98
  • TABLE 130 AUSTRALIA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 98
  • TABLE 131 AUSTRALIA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 98
  • TABLE 132 AUSTRALIA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 99
  • TABLE 133 AUSTRALIA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 99
  • TABLE 134 REPUBLIC OF KOREA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 100
  • TABLE 135 REPUBLIC OF KOREA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 100
  • TABLE 136 REPUBLIC OF KOREA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 101
  • TABLE 137 REPUBLIC OF KOREA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 101
  • TABLE 138 REPUBLIC OF KOREA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 101
  • TABLE 139 REPUBLIC OF KOREA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 102
  • TABLE 140 REST OF ASIA PACIFIC CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 102
  • TABLE 141 REST OF ASIA PACIFIC CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 103
  • TABLE 142 REST OF ASIA PACIFIC CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 103
  • TABLE 143 REST OF ASIA PACIFIC IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 103
  • TABLE 144 REST OF ASIA PACIFIC CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 104
  • TABLE 145 REST OF ASIA PACIFIC CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 104
  • TABLE 146 MIDDLE EAST & AFRICA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 106
  • TABLE 147 MIDDLE EAST & AFRICA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 107
  • TABLE 148 MIDDLE EAST & AFRICA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 107
  • TABLE 149 MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 107
  • TABLE 150 MIDDLE EAST & AFRICA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 108
  • TABLE 151 MIDDLE EAST & AFRICA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 108
  • TABLE 152 UAE CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 109
  • TABLE 153 UAE CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 109
  • TABLE 154 UAE CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 109
  • TABLE 155 UAE IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 110
  • TABLE 156 UAE CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 110
  • TABLE 157 UAE CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 111
  • TABLE 158 SAUDI ARABIA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 111
  • TABLE 159 SAUDI ARABIA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 112
  • TABLE 160 SAUDI ARABIA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 112
  • TABLE 161 SAUDI ARABIA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 112
  • TABLE 162 SAUDI ARABIA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 113
  • TABLE 163 SAUDI ARABIA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 113
  • TABLE 164 OMAN CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 114
  • TABLE 165 OMAN CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 114
  • TABLE 166 OMAN CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 114
  • TABLE 167 OMAN IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 115
  • TABLE 168 OMAN CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 115
  • TABLE 169 OMAN CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 116
  • TABLE 170 KUWAIT CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 116
  • TABLE 171 KUWAIT CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 117
  • TABLE 172 KUWAIT CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 117
  • TABLE 173 KUWAIT IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 117
  • TABLE 174 KUWAIT CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 118
  • TABLE 175 KUWAIT CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 118
  • TABLE 176 QATAR CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 119
  • TABLE 177 QATAR CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 119
  • TABLE 178 QATAR CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 119
  • TABLE 179 QATAR IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 120
  • TABLE 180 QATAR CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 120
  • TABLE 181 QATAR CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 121
  • TABLE 182 REST OF MIDDLE EAST & AFRICA CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 TO 2027 (USD MILLION) 121
  • TABLE 183 REST OF MIDDLE EAST & AFRICA CARDIAC MONITORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 122
  • TABLE 184 REST OF MIDDLE EAST & AFRICA CARDIAC PACEMAKERS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 122
  • TABLE 185 REST OF MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC PACEMAKER MARKET BY TECHNOLOGY, 2020 TO 2027 (USD MILLION) 123
  • TABLE 186 REST OF MIDDLE EAST & AFRICA CARDIAC DEFIBRILLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 123
  • TABLE 187 REST OF MIDDLE EAST & AFRICA CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 TO 2027 (USD MILLION) 124

LIST OF FIGURES

  • FIGURE 1 GLOBAL CARDIOVASCULAR APPLICATION MARKET, 2020 TO 2027 (USD MILLION) 14
  • FIGURE 2 GLOBAL CARDIOVASCULAR APPLICATION MARKET SHARE BY DEVICE, 2020 (%) 15
  • FIGURE 3 GLOBAL CARDIOVASCULAR APPLICATION MARKET SHARE BY END USER, 2020 (%) 15
  • FIGURE 4 GLOBAL CARDIOVASCULAR APPLICATION MARKET SHARE BY REGION, 2020 (%) 16
  • FIGURE 5 MARKET STRUCTURE OF GLOBAL CARDIOVASCULAR APPLICATION MARKET 18
  • FIGURE 6 RESEARCH METHODOLOGY 19
  • FIGURE 7 VALUE CHAIN: CORONARY PRESSURE MONITORS 23
  • FIGURE 8 PORTER'S FIVE FORCES MODEL 25
  • FIGURE 9 MAKRET DYNAMICS 28
  • FIGURE 10 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY DEVICE, 2020 & 2027 (USD MILLION) 35
  • FIGURE 11 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY END USER, 2020 & 2027 (USD MILLION) 40
  • FIGURE 12 GLOBAL CARDIOVASCULAR APPLICATION MARKET BY REGION, 2020 & 2027 (USD MILLION) 45
  • FIGURE 13 AMERICA CARDIOVASCULAR APPLICATION MARKET SHARE BY REGION, 2020 (%) 47
  • FIGURE 14 NORTH AMERICA CARDIOVASCULAR APPLICATION MARKET SHARE BY COUNTRY, 2020 (%) 50
  • FIGURE 15 EUROPE CARDIOVASCULAR APPLICATION MARKET SHARE BY REGION, 2020 (%) 61
  • FIGURE 16 WESTERN EUROPE CARDIOVASCULAR APPLICATION MARKET SHARE BY COUNTRY, 2020 (%) 64
  • FIGURE 17 ASIA PACIFIC CARDIOVASCULAR APPLICATION MARKET SHARE BY REGION, 2020 (%) 86
  • FIGURE 18 ASIA PACIFIC CARDIOVASCULAR APPLICATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 87
  • FIGURE 19 MIDDLE EAST & AFRICA CARDIOVASCULAR APPLICATION MARKET SHARE BY REGION, 2020 (%) 105
  • FIGURE 20 MIDDLE EAST & AFRICA CARDIOVASCULAR APPLICATION MARKET BY REGION, 2020 TO 2027 (USD MILLION) 106
  • FIGURE 21 GOBAL CARDIOVASCULAR APPLICATION MARKET, COMPANY SHARE ANALYSIS, 2020 (%) 125